You are here

IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Persistent Pulmonary Hypertension of the Newborn
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0-72
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Babies respiratory failure associated with idiopathic PPHN, meconium aspiration, sepsis or
pneumonia

- Oxygenation index >15 and

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Congenital anomaly

- Large left to right intracardiac or ductal shunt

- Already on inhaled nitric oxide

NCT01360671
Pfizer
Withdrawn
IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now